Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James C Watson

Showing results (81-90 of 95) with videos related to

Pageof 10
Sort By:
Journal of Surgical Oncology|October 23, 2008
Phase II trial of neoadjuvant/adjuvant imatinib mesylate (IM) for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumor (GIST): early results of RTOG 0132/ACRIN 6665Burton L Eisenberg, Jonathan Harris, Charles D Blanke, et al.
Seminars in Oncology|January 10, 2006
Can molecular imaging predict response to preoperative chemoradiation in patients with rectal cancer? A Fox Chase Cancer Center prospective experienceAndre Konski, John Hoffman, Elin Sigurdson, et al.
Journal of Pain Research|October 28, 2017
Outcomes of C1-2 joint injectionsChristopher M Aiudi, W Michael Hooten, Rebecca A Sanders, et al.
Pancreas|December 12, 2013
Potential prognostic biomarkers of pancreatic cancerKathryn T Chen, Phillip D Kim, Kelly A Jones, et al.
Pain|January 12, 2021
Ultrasound-guided transversus abdominis plane block vs trigger point injections for chronic abdominal wall pain: a randomized clinical trialSusan M Moeschler, E Morgan Pollard, Matthew J Pingree, et al.
American Journal of Clinical Oncology|May 12, 2010
Phase II and coagulation cascade biomarker study of bevacizumab with or without docetaxel in patients with previously treated metastatic pancreatic adenocarcinomaIgor A Astsaturov, Neal J Meropol, R Katherine Alpaugh, et al.
Annals of Surgical Oncology|December 29, 2011
Phase II trial of neoadjuvant/adjuvant imatinib mesylate for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumors: long-term follow-up results of Radiation Therapy Oncology Group 0132Dian Wang, Qiang Zhang, Charles D Blanke, et al.
International Journal of Radiation Oncology, Biology, Physics|July 22, 2011
Radiation Therapy Oncology Group 0247: a randomized Phase II study of neoadjuvant capecitabine and irinotecan or capecitabine and oxaliplatin with concurrent radiotherapy for patients with locally advanced rectal cancerStuart J Wong, Kathryn Winter, Neal J Meropol, et al.
Annals of Surgical Oncology|August 21, 2010
Defining venous involvement in borderline resectable pancreatic cancerYun Shin Chun, Barton N Milestone, James C Watson, et al.
The Clinical Journal of Pain|February 8, 2022
Comparative Effectiveness of Landmark-guided Greater Occipital Nerve (GON) Block at the Superior Nuchal Line Versus Ultrasound-guided GON Block at the Level of C2: A Randomized Clinical Trial (RCT)Narayan R Kissoon, Travis G O'Brien, Markus A Bendel, et al.
Pageof 10

Showing results (81-90 of 95) with videos related to

Sort By:
Pageof 10
Journal of Surgical Oncology|October 23, 2008
Phase II trial of neoadjuvant/adjuvant imatinib mesylate (IM) for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumor (GIST): early results of RTOG 0132/ACRIN 6665Burton L Eisenberg, Jonathan Harris, Charles D Blanke, et al.
Seminars in Oncology|January 10, 2006
Can molecular imaging predict response to preoperative chemoradiation in patients with rectal cancer? A Fox Chase Cancer Center prospective experienceAndre Konski, John Hoffman, Elin Sigurdson, et al.
Journal of Pain Research|October 28, 2017
Outcomes of C1-2 joint injectionsChristopher M Aiudi, W Michael Hooten, Rebecca A Sanders, et al.
Pancreas|December 12, 2013
Potential prognostic biomarkers of pancreatic cancerKathryn T Chen, Phillip D Kim, Kelly A Jones, et al.
Pain|January 12, 2021
Ultrasound-guided transversus abdominis plane block vs trigger point injections for chronic abdominal wall pain: a randomized clinical trialSusan M Moeschler, E Morgan Pollard, Matthew J Pingree, et al.
American Journal of Clinical Oncology|May 12, 2010
Phase II and coagulation cascade biomarker study of bevacizumab with or without docetaxel in patients with previously treated metastatic pancreatic adenocarcinomaIgor A Astsaturov, Neal J Meropol, R Katherine Alpaugh, et al.
Annals of Surgical Oncology|December 29, 2011
Phase II trial of neoadjuvant/adjuvant imatinib mesylate for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumors: long-term follow-up results of Radiation Therapy Oncology Group 0132Dian Wang, Qiang Zhang, Charles D Blanke, et al.
International Journal of Radiation Oncology, Biology, Physics|July 22, 2011
Radiation Therapy Oncology Group 0247: a randomized Phase II study of neoadjuvant capecitabine and irinotecan or capecitabine and oxaliplatin with concurrent radiotherapy for patients with locally advanced rectal cancerStuart J Wong, Kathryn Winter, Neal J Meropol, et al.
Annals of Surgical Oncology|August 21, 2010
Defining venous involvement in borderline resectable pancreatic cancerYun Shin Chun, Barton N Milestone, James C Watson, et al.
The Clinical Journal of Pain|February 8, 2022
Comparative Effectiveness of Landmark-guided Greater Occipital Nerve (GON) Block at the Superior Nuchal Line Versus Ultrasound-guided GON Block at the Level of C2: A Randomized Clinical Trial (RCT)Narayan R Kissoon, Travis G O'Brien, Markus A Bendel, et al.
Pageof 10